References
- HawkinsRCAge and gender as risk factors for hyponatremia and hypernatremiaClin Chim Acta20033371–216917214568195
- WaldRJaberBLPriceLLUpadhyayAMadiasNEImpact of hospital-associated hyponatremia on selected outcomesArch Intern Med2010170329430220142578
- TerzianCFryeEBPiotrowskiZHAdmission hyponatremia in the elderly: factors influencing prognosisJ Gen Intern Med19949289918164083
- BennaniSLAbouqalRZeggwaghAAIncidence, causes and prognostic factors of hyponatremia in intensive careRev Med Interne200324422422912706778
- VerbalisJGGoldsmithSRGreenbergADiagnosis, evaluation, and treatment of hyponatremia: expert panel recommendationsAm J Med201312610 Suppl 1S1S4224074529
- RobertsonGLRegulation of arginine vasopressin in the syndrome of inappropriate antidiuresisAm J Med20061197 Suppl 1S36S4216843083
- VAPRISOL (conivaptan hydrochloride) Injection, for intravenous useNashville, TNCumberland Pharmaceuticals Inc.2014
- SAMSCA (tolvaptan) tablets for oral useTokyo, JapanOtsuka Pharmaceutical Co., Ltd.2014
- TaharaASaitoMSugimotoTPharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonistNaunyn Schmiedebergs Arch Pharmacol1998357163699459574
- YamamuraYNakamuraSItohSOPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in ratsJ Pharmacol Exp Ther199828738608679864265
- GreenbergAVerbalisJGAminANCurrent treatment practice and outcomes. Report of the hyponatremia registryKidney Int201588116717725671764
- DiringerMNZazuliaARHyponatremia in neurologic patients: consequences and approaches to treatmentNeurologist200612311712616688013
- MohmandHKIssaDAhmadZCappuccioJDKouidesRWSternsRHHypertonic saline for hyponatremia: risk of inadvertent overcorrectionClin J Am Soc Nephrol2007261110111717913972
- SpasovskiGVanholderRAllolioBClinical practice guideline on diagnosis and treatment of hyponatraemiaEur J Endocrinol20141703G1G4724569125
- KorenMJHamadAKlasenSAbeyratneAMcNuttBEKalraSEfficacy and safety of 30-minute infusions of conivaptan in euvolemic and hypervolemic hyponatremiaAm J Health Syst Pharm201168981882721515866
- BarberJMcKeeverTMMcDowellSEA systematic review and meta-analysis of thiazide-induced hyponatraemia: time to reconsider electrolyte monitoring regimens after thiazide initiation?Br J Clin Pharmacol201579456657725139696
- DiaconuCCBalaceanuABartosDDiuretics, first-line antihypertensive agents: are they always safe in the elderly?Rom J Intern Med2014522879025338344
- FrenkelNJVogtLDe RooijSEThiazide-induced hyponatraemia is associated with increased water intake and impaired urea-mediated water excretion at low plasma antidiuretic hormone and urine aquaporin-2J Hypertens201533362763325426567
- SardarGKEilbertWPSevere hyponatremia associated with thiazide diuretic useJ Emerg Med201548330530925499401
- HussainIAhmadZGargAExtreme hypercholesterolemia presenting with pseudohyponatremia – a case report and review of the literatureJ Clin Lipidol20159226026425911084
- AwTCKiechleFLPseudohyponatremiaAm J Emerg Med1985332362393994801
- RastogiDPelterMADeamerRLEvaluations of hospitalizations associated with thiazide-associated hyponatremiaJ Clin Hypertens (Greenwich)201214315816422372775
- SternsRHNigwekarSUHixJKThe treatment of hyponatremiaSemin Nephrol200929328229919523575
- AylwinSBurstVPeriARunkleIThatcherNDos and don’ts in the management of hyponatremiaCurr Med Res Opin20151426